HIGHLIGHTS
- who: Julia Malinovskaya and collaborators from the Drug Delivery Systems Laboratory, DMendeleev of Chemical Technology of Russia have published the research work: Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy, in the Journal: (JOURNAL)
- what: In this study the ability of the dual NP-based theranostic system to accumulate in the tumor was evaluated in vivo using intravital microscopy (IVM) and MRI. The aim of this study was to evaluate the potential of the hMNP as a diagnostic companion for the model therapeutic poly(lactide-co-glycolide . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.